SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-100475
Filing Date
2016-05-10
Accepted
2016-05-10 16:31:51
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v438437_10q.htm 10-Q 488059
2 EXHIBIT 31.1 v438437_ex31-1.htm EX-31.1 9917
3 EXHIBIT 31.2 v438437_ex31-2.htm EX-31.2 10093
4 EXHIBIT 32.1 v438437_ex32-1.htm EX-32.1 4255
5 EXHIBIT 32.2 v438437_ex32-2.htm EX-32.2 4037
  Complete submission text file 0001144204-16-100475.txt   3380253

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20160331.xml EX-101.INS 646906
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20160331.xsd EX-101.SCH 43181
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20160331_cal.xml EX-101.CAL 33777
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20160331_def.xml EX-101.DEF 227344
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20160331_lab.xml EX-101.LAB 287509
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20160331_pre.xml EX-101.PRE 257628
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 161636231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences